Evidence map›Paper›PMID 34334421›Full record

ArticleJournal of Parkinson's disease2021

Virtual Reality Functional Capacity Assessment Tool (VRFCAT-SL) in Parkinson's Disease.

Travis H Turner, Alexandra Atkins, Richard S E Keefe

Abstract read
In one paragraph

Article in Journal of Parkinson's disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Travis H TurnerDepartment of Neurology, Medical University of South Carolina, Charleston, SC, USA.
Alexandra AtkinsVeraSci, Inc., Durham, NC, USA.
Richard S E KeefeVeraSci, Inc., Durham, NC, USA.

Funding

The Virtual Reality Functional Capacity Assessment Tool (VRFCAT) Validation StudyR44MH084240 · NIMH · VERASCI, LLC · PI ATKINS, ALEXANDRA STRICKLAND · 2012 to 2018
$3.4M
Validation of a Performance Based Measure of Functioning in MCI and Early ADR44AG058345 · NIA · VERASCI, LLC · PI SCHOEMAKER-MARCOTTE, DOROTHEE · 2017 to 2019
$1.6M
NIA NIH HHS R44 AG058345NIMH NIH HHS R44 MH084240
6 · The paper itself

Abstract

backgroundCognitive impairment is common in Parkinson's disease (PD) and highly associated with loss of independence, caregiver burden, and assisted living placement. The need for cognitive functional capacity tools validated for use in PD clinical and research applications has thus been emphasized in the literature. The Virtual Reality Functional Capacity Assessment Tool (VRFCAT-SL) is a tablet-based instrument that assesses proficiency for performing real world tasks in a highly realistic environment.

objectiveThe present study explored application of the VRFCAT-SL in clinical assessments of patients with PD. Specifically, we examined associations between VRFCAT-SL performance and measures of cognition, motor severity, and self-reported cognitive functioning.

methodsThe VRFCAT-SL was completed by a sample of 29 PD patients seen in clinic for a comprehensive neuropsychological evaluation. Fifteen patients met Movement Disorders Society Task Force criteria for mild cognitive impairment (PD-MCI); no patients were diagnosed with dementia. Non-parametric correlations between VRFCAT-SL performance and standardized neuropsychological tests and clinical measures were examined.

resultsVRFCAT-SL performance was moderately associated with global rank on neuropsychological testing and discriminated PD-MCI. Follow-up analyses found completion time was associated with visual memory, sustained attention, and set-switching, while errors were associated with psychomotor inhibition. No clinical or motor measures were associated with VRFCAT-SL performance. Self-report was not associated with VRFCAT-SL or neuropsychological test performance.

conclusionThe VRFCAT-SL appears to provide a useful measure of cognitive functional capacity that is not confounded by PD motor symptoms. Future studies will examine utility in PD dementia.

Indexed as

Parkinson DiseaseVirtual RealityHumansNeuropsychological TestsAssessmentcognitive capacityfunctional capacityfunctional outcomemild cognitive impairmentneuropsychologyParkinson’s diseasevirtual reality

Identifiers

PMID34334421
PMCPMC8609696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.